NC
XP icon

Nucleo Capital’s XP XP Stock Holding History

Nucleo Capital’s Portfolio XP Stock Details XP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-838,330
Closed -$31.6M – 3
2021
Q1 		$31.6M Sell
838,330
-196,300
-19% -$8.38M 18.73% 3
2020
Q4 		$41M Buy
1,034,630
+141,300
+16% +$5.77M 11.64% 4
2020
Q3 		$37.2M Buy
893,330
+2,330
+0.3% +$106K 12.94% 4
2020
Q2 		$37.4M Buy
+891,000
New +$27.3M 15.42% 4

Other funds holding XP

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $156M AUM
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
SI
Squadra Investments Rio De Janeiro, Brazil $894M AUM 33.04% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Nucleo Capital's XP Position: Q2 2021 in Review

Nucleo Capital sold out of XP (XP) in Q2 2021, closing a stake of 838,330 shares — an estimated $31.6M sold.

Nucleo Capital first reported a position in XP in Q2 2020 and held it in 4 quarters. The position peaked at $41M in Q4 2020. 166 funds tracked by Wall St. Rank hold XP as of Q2 2021.

  • Nucleo Capital reported no remaining XP position as of Q2 2021 after selling out during the quarter.
  • Nucleo Capital sold 838,330 XP shares in Q2 2021, an estimated $31.6M.
  • Nucleo Capital first reported a position in XP in Q2 2020 and held it in 4 quarters.
  • Nucleo Capital's XP position peaked at $41M in Q4 2020.
  • 166 funds tracked by Wall St. Rank held XP as of Q2 2021.

Based on Nucleo Capital's 13F filing for Q2 2021, filed 13 Aug 2021.